Collectively, these studies show that the CD134–CD252 pathway is involved in regulating inflammation by reducing the production of cytokines such as IL-4 and IL-10, known to perpetuate inflammation in SLE. The gene discussed is IL10; the disease is systemic lupus erythematosus.